Toggle navigation
About
Abstract
Editorial Board
Subscription & Newsletter
Contact
Issues
This issue
23-3
All issues
Download PDF
Download EPUB
Editor's Selection
This issue
23-3
Browse by topic
Browse by contributor
Dialogue & Opinion
Abstracts
Abstracts
Search
Classification List
Abstracted Journals
Index of Authors
News & Reports
Home
Abstracts
Index of Authors
Author #27216
advertisement
Xu J
49
Showing records 1 to 25 |
Display all abstracts from
Xu J
106568
The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
Huang S
European Journal of Dermatology
2022; 32: 589-596
106448
Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Zhang Y
JMIR public health and surveillance
2022; 8: e38182
105280
Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhao Y
Drug Delivery
2022; 29: 613-623
105762
Tongqiao Mingmu formula alleviates retinal ganglion cell autophagy through PI3K/AKT/mTOR pathway
Wang L
Anatomical RecordProceedings of the National Academy of Sciences of the United States of America
2023; 306: 3120-3130
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Jiang J
Ophthalmic Research
2022; 0:
106301
CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain
Qiu C
Journal of cellular and molecular medicine
2022; 26: 5858-5871
105280
Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Huang C
Drug Delivery
2022; 29: 613-623
106568
The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
Yang Y
European Journal of Dermatology
2022; 32: 589-596
105762
Tongqiao Mingmu formula alleviates retinal ganglion cell autophagy through PI3K/AKT/mTOR pathway
Yu T
Anatomical RecordProceedings of the National Academy of Sciences of the United States of America
2023; 306: 3120-3130
106448
Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Chen C
JMIR public health and surveillance
2022; 8: e38182
106301
CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain
Wang C
Journal of cellular and molecular medicine
2022; 26: 5858-5871
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Xu J
Ophthalmic Research
2022; 0:
105762
Tongqiao Mingmu formula alleviates retinal ganglion cell autophagy through PI3K/AKT/mTOR pathway
Dong F
Anatomical RecordProceedings of the National Academy of Sciences of the United States of America
2023; 306: 3120-3130
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Tao Y
Ophthalmic Research
2022; 0:
106301
CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain
Sun X
Journal of cellular and molecular medicine
2022; 26: 5858-5871
106568
The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
Ouyang Z
European Journal of Dermatology
2022; 32: 589-596
106448
Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Huang L
JMIR public health and surveillance
2022; 8: e38182
105280
Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Zhang Z
Drug Delivery
2022; 29: 613-623
106448
Associations Among Multimorbid Conditions in Hospitalized Middle-aged and Older Adults in China: Statistical Analysis of Medical Records
Liu G
JMIR public health and surveillance
2022; 8: e38182
106568
The risk of glaucoma associated with phacomatosis cesioflammea and phacomatosis cesioflammeo-marmorata
Guo X
European Journal of Dermatology
2022; 32: 589-596
105280
Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Hong J
Drug Delivery
2022; 29: 613-623
106364
A Novel and Reversible Experimental Primate Ocular Hypertension Model: Blocking Schlemm's Canal
Hu C
Ophthalmic Research
2022; 0:
106301
CXC- receptor 2 promotes extracellular matrix production and attenuates migration in peripapillary human scleral fibroblasts under mechanical strain
Xu J
Journal of cellular and molecular medicine
2022; 26: 5858-5871
105762
Tongqiao Mingmu formula alleviates retinal ganglion cell autophagy through PI3K/AKT/mTOR pathway
Xu J
Anatomical RecordProceedings of the National Academy of Sciences of the United States of America
2023; 306: 3120-3130
105280
Sustained release of brimonidine from BRI@SR@TPU implant for treatment of glaucoma
Xu J
Drug Delivery
2022; 29: 613-623
«
1
2
»
Issue
23-3
Table of Contents
Editor's Selection
PDF
EPUB
Change Issue
26-1
25-4
25-3
25-2
25-1
24-4
24-3
24-1/2
23-4
23-3
23-2
23-1
22-4
22-3
22-2
22-1
21-4
21-3
21-2
21-1
20-4
20-3
20-2
20-1
19-4
19-3
19-2
19-1
18-4
18-3
18-2
18-1
17-4
17-3
17-2
17-1
16-4
16-3
16-2
16-1
15-4
15-3
15-2
15-1
14-4
14-3
14-2
14-1
13-4
13-3
13-2
13-1
12-4
12-3
12-2
12-1
11-4
11-3
11-2
11-1
10-4
10-3
10-2
10-1
9-4
9-3
9-2
9-1
8-4
8-3
8-2
8-1
7-3
7-2
7-1
6-3
6-2
6-1
5-3
5-2
5-1
4-3
4-2
4-1
3-3
3-2
3-1
2-3
2-2
2-1
1-3
1-2
1-1
advertisement
We would like to use Google Analytics to see which parts of the review are read. It is only used to count visits, never for advertising.
Privacy statement
Decline
Accept